DepoMed, Inc. (NASDAQ:DEPO)
CAPS Rating:
A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.
RSS Headlines
Fool UK
Recs
Significant insider buying ahead of Serada data, and Gralise launch